Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Pramlintide

A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

AstraZeneca · Phase 2 · Completed · Enrollment 258

NCT00402077

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
1n/rn/rn/rn/r
2n/rn/rn/rn/r
3n/rn/rn/rn/r
4n/rn/rn/rn/r

Not shown

  • 1: endpoint not reported
  • 2: endpoint not reported
  • 3: endpoint not reported
  • 4: endpoint not reported